Understanding the Pathophysiology
Age-related macular degeneration (AMD) is a chronic, progressive retinal disease that primarily affects the
macula, the central and most sensitive part of the retina responsible for sharp, detailed vision. The provided literature confirms that AMD leads to "irreversible central vision loss" due to progressive damage to the central retina
[1][3]. This damage occurs in the late stages, which manifest as either
neovascular (wet) AMD, characterized by abnormal blood vessel growth under the macula, or
atrophic (dry) AMD, involving the gradual breakdown of retinal pigment epithelial cells and photoreceptors
[1]. The functional consequence of this macular damage is a loss of central visual acuity, making it difficult to see fine details, recognize faces, or read, which aligns directly with the correct assessment finding.
Analyzing the Correct Answer (Option 2)
The finding of "distorted central vision with difficulty seeing fine details" is the hallmark clinical presentation of AMD. This symptom, often referred to as
metamorphopsia, is explicitly described in the literature as a characteristic feature of the disease, with patients experiencing "visual distortions, image blurring, and gradual central vision loss"
[4]. A case report further illustrates this, detailing a patient with bilateral AMD whose corrected distance visual acuity was reduced to
20/125 (6/37.5) and near acuity to
2.5M (20/125), demonstrating a profound inability to discern fine details even with refractive correction
[2]. This central vision deficit is a direct result of the pathological process limited to the macula, while the peripheral retina remains unaffected until very late stages.
Differentiating from Other Conditions
The other options describe symptoms of different ocular pathologies, and distinguishing them is a critical skill for the NCLEX-RN.
-
Option 1 (Complete loss of peripheral vision with intact central vision) is the classic presentation of
primary open-angle glaucoma, not AMD. In glaucoma, damage to the optic nerve fibers typically begins at the periphery, causing "tunnel vision" while sparing central acuity until the end stage. AMD does the opposite, destroying central vision first.
-
Option 3 (Sudden onset of severe eye pain with halos around lights) is a hallmark of
acute angle-closure glaucoma, a medical emergency. AMD is a painless condition with a gradual, not sudden, onset of vision loss
[4].
-
Option 4 (Progressive loss of night vision with difficulty adapting to darkness) is more indicative of
retinitis pigmentosa or severe vitamin A deficiency, which primarily affect the rod photoreceptors concentrated in the peripheral retina. While patients with AMD may experience some difficulties in low light, the primary and most characteristic deficit is a progressive loss of central, not night, vision.
Clinical Assessment and Nursing Implications
For a
72-year-old client, a nurse's assessment should focus on functional vision changes. The strongest non-modifiable risk factors are age and family history, while smoking and cardiovascular disease are key modifiable contributors
[1]. When assessing a client with suspected AMD, the nurse should inquire about difficulty with activities requiring fine central vision, such as reading, sewing, or seeing faces clearly. The use of an
Amsler grid is a standard screening tool to detect the metamorphopsia and central scotomas characteristic of this condition. The literature emphasizes that AMD significantly impairs a patient's ability to perform everyday activities and reduces their quality of life, making safety assessments—such as fall risk evaluation and medication management—a nursing priority
[4].
References (research sources)
- [1]
Age-related macular degeneration: Updates for general practitioners.Research articleEiselen C, Long M, Chong EW. (2026) · DOI: 10.31128/ajgp-10-25-7882
- [2]
Clinical Low Vision Rehabilitation Interventions in Age-Related Macular Degeneration: A Case Report.Case reportAl-Tamimi NY, Amer M, Graini FNE. (2026) · DOI: 10.7759/cureus.109419
- [3]
Retinotopic mapping of cortical plasticity in age-related macular degenerationResearch articleDuret A, Vallée J, Lahutsina A, Rdeini D, Coiffé ML, Gocho K, Sheynikhovich D, Ramanoel S. (2026) · DOI: 10.31234/osf.io/yaqmz_v1
- [4]
Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study.Research articleNowak M, Cybulska AM, Derezińska A, Grochans E, Panczyk M, Kęcka K, Rachubińska K. (2026) · DOI: 10.3389/fmed.2026.1731481